SEC Form 4 · accession 0001104659-18-066381
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonardus H.T. Van der Ploeg
Officer — Chief Scientific Officer
Period of report
Nov 2, 2018
Accepted (ET)
Nov 6, 2018 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2018 | M | 8,200 | $4.59 | A | 60,539 | D | |
| Common Stock | Nov 2, 2018 | M | 10,000 | $6.14 | A | 70,539 | D | |
| Common Stock | Nov 2, 2018 | M | 10,000 | $7.52 | A | 80,539 | D | |
| Common StockF2 | Nov 2, 2018 | S | 38,000 | $30.09 | D | 42,539 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $4.59 | Nov 2, 2018 | M | 8,200 | D | — | Nov 16, 2025 | Common Stock | 8,200 | 33,471 | D |
| Employee Stock Option (Right to Buy)F4 | $6.14 | Nov 2, 2018 | M | 10,000 | D | — | Apr 4, 2027 | Common Stock | 10,000 | 55,430 | D |
| Employee Stock Option (Right to Buy)F5 | $7.52 | Nov 2, 2018 | M | 10,000 | D | — | Dec 30, 2025 | Common Stock | 10,000 | 30,894 | D |
Explanation of responses
- F1On November 2, 2018, Mr. Van der Ploeg sold 38,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2This transaction was executed in multiple trades at prices ranging from $30.00 to $30.31, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- F3The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
- F4The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017.
- F5The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.